Protocol - COVID-19 Vaccination - Adult
Description
This protocol has 13 items asking about the COVID-19 vaccination and enrollment in the vaccine trial.
Specific Instructions
None
Availability
Protocol
1. Have you ever been given a vaccine for COVID-19 or enrolled in the COVID-19 clinical vaccine trials?
1 [ ] Yes
2 [ ] No
3 [ ] Dont know
4 [ ] Refuse to answer
2. How many doses of the COVID-19 vaccine have you received to date?
1 [ ] 1
2 [ ] 2
3 [ ] 3
4 [ ] Other (specify)
5 [ ] Refuse to answer
3. Please specify the other number of doses of the COVID-19 vaccine you have received to date: __________________________________
4. Which COVID-19 vaccine trial or vaccine were you given as your first dose?
1 [ ] Moderna mRNA vaccine
2 [ ] Pfizer mRNA vaccine
3 [ ] AstraZeneca attenuated viral vaccine
4 [ ] Johnson & Johnson
5 [ ] Novavax
6 [ ] Other (specify)
7 [ ] Dont know
8 [ ] Refuse to answer
5. Please specify other COVID-19 vaccine you were given as your first dose: __________________________________
6. If you participated in the COVID-19 clinical vaccine trials, do you know if you received a placebo or the vaccine? A placebo is a harmless substance that looks like the vaccine being tested, but does not contain active ingredients.
1 [ ] I received a placebo
2 [ ] I received the vaccine
3 [ ] I was not part of the COVID-19 clinical vaccine trials
4 [ ] Dont know
5 [ ] Refuse to answer
7. In which month did you receive the first dose of the COVID-19 vaccine?
*must provide value _____
8. On which day did you receive the first dose of the COVID-19 vaccine?
*must provide value _____
9. In which year did you receive the first dose of the COVID-19 vaccine?
*must provide value ______
10. Which COVID-19 vaccine trial or vaccine were you given as your second dose?
1 [ ] Moderna mRNA vaccine
2 [ ] Pfizer mRNA vaccine
3 [ ] AstraZeneca attenuated viral vaccine
4 [ ] Johnson & Johnson
5 [ ] Novavax
6 [ ] Other (specify)
7 [ ] Dont know
8 [ ] Refuse to answer
11. Please specify other COVID-19 vaccine you were given as your second dose: __________________________________
12. In which month did you receive or will you receive the second dose of the COVID-19 vaccine?
*must provide value ______
13. On which day did you receive or will you receive the second dose of the COVID-19 vaccine?
*must provide value ______
14. In which year did you receive or will you receive the second dose of the COVID-19 vaccine?
*must provide value ______
15. Which COVID-19 vaccine trial or vaccine were you given as your third dose?
1 [ ] Moderna mRNA vaccine
2 [ ] Pfizer mRNA vaccine
3 [ ] AstraZeneca attenuated viral vaccine
4 [ ] Johnson & Johnson
5 [ ] Novavax
6 [ ] Other (specify)
7 [ ] Dont know
8 [ ] Refuse to answer
16. Please specify other COVID-19 vaccine you were given as your third dose: __________________________________
17. In which month did you receive or will you receive the third dose of the COVID-19 vaccine?
*must provide value ______
18. On which day did you receive or will you receive the third dose of the COVID-19 vaccine?
*must provide value ______
19. In which year did you receive or will you receive the third dose of the COVID-19 vaccine?
*must provide value ______
Personnel and Training Required
None
Equipment Needs
None
Requirements
Requirement Category | Required |
---|---|
Major equipment | No |
Specialized training | No |
Specialized requirements for biospecimen collection | No |
Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Self-administered questionnaire
Lifestage
Adult, Senior
Participants
Adults aged 18 years or older
Selection Rationale
PhenX used input from the PhenX Steering Committee to enable rapid response and release of COVID-19 related protocols in the Toolkit.
Language
English
Standards
Standard | Name | ID | Source |
---|
Derived Variables
None
Process and Review
Not applicable
Protocol Name from Source
Johns Hopkins COVID Long Study
Source
Johns Hopkins COVID Long Study, questions from page 5-6
General References
None
Protocol ID
940401
Variables
Export VariablesVariable Name | Variable ID | Variable Description | dbGaP Mapping | |
---|---|---|---|---|
PX940401_Covid_Vaccination_Adult_Dose_First | ||||
PX940401040000 | Which COVID-19 vaccine trial or vaccine were more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_First_Day | ||||
PX940401070000 | On which day did you receive the first dose more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_First_Month | ||||
PX940401060000 | In which month did you receive the first more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_First_Other | ||||
PX940401040100 | Please specify other COVID-19 vaccine you more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_First_Year | ||||
PX940401080000 | In which year did you receive the first dose more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Placebo | ||||
PX940401050000 | If you participated in the COVID-19 clinical more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Second | ||||
PX940401090000 | Which COVID-19 vaccine trial or vaccine were more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Second_Day | ||||
PX940401110000 | On which day did you receive or will you more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Second_Month | ||||
PX940401100000 | In which month did you receive or will you more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Second_Other | ||||
PX940401090100 | Please specify other COVID-19 vaccine you more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Second_Year | ||||
PX940401120000 | In which year did you receive or will you more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Third | ||||
PX940401130000 | Which COVID-19 vaccine trial or vaccine were more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Third_Day | ||||
PX940401150000 | On which day did you receive or will you more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Third_Month | ||||
PX940401140000 | In which month did you receive or will you more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Third_Other | ||||
PX940401130100 | Please specify other COVID-19 vaccine you more | N/A | ||
PX940401_Covid_Vaccination_Adult_Dose_Third_Year | ||||
PX940401160000 | In which year did you receive or will you more | N/A | ||
PX940401_Covid_Vaccination_Adult_Ever_Given | ||||
PX940401010000 | Have you ever been given a vaccine for more | N/A | ||
PX940401_Covid_Vaccination_Adult_Number_Doses | ||||
PX940401020000 | How many doses of the COVID-19 vaccine have more | N/A | ||
PX940401_Covid_Vaccination_Adult_Number_Doses_Other | ||||
PX940401030000 | Please specify the other number of doses of more | N/A |
Measure Name
COVID-19 Vaccination
Release Date
March 17, 2023
Definition
This is a measure of an individual’s history and treatment of COVID-19 vaccination
Purpose
Presence of lingering COVID-19 symptoms is a sign of Long COVID, and use of this measure helps with understanding if people took the COVID-19 vaccine, which one did they take, if they took a placebo, and how many doses of the vaccine did they take.
Keywords
Johns Hopkins, COVID, Vaccine, COVID-19 clinical vaccine trials, vaccine doses, placebo
Measure Protocols
Protocol ID | Protocol Name |
---|---|
940401 | COVID-19 Vaccination - Adult |
940402 | COVID-19 Vaccination - Child |
Publications
There are no publications listed for this protocol.